Digital Content 
NEWS #PharmaBuzz
30 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/30/3178024/0/en/BBOT-Announces-Poster-Presentations-at-the-San-Antonio-Breast-Cancer-Symposium-SABCS.html
30 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/30/3177971/0/en/Olema-Oncology-to-Present-Trial-in-Progress-Poster-for-Phase-3-OPERA-02-Trial-of-Palazestrant-Plus-Ribociclib-at-SABCS-2025.html
18 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/18/3168941/0/en/Olema-Oncology-Announces-New-Data-from-the-Phase-1b-2-Trial-of-Palazestrant-Plus-Ribociclib-in-ER-HER2-Metastatic-Breast-Cancer-at-ESMO-2025.html
01 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/01/3091466/0/en/Novartis-Kisqali-reduces-risk-of-recurrence-in-younger-patients-with-early-breast-cancer-in-NATALEE-subgroup-analysis.html
28 Mar 2025
// PRESS RELEASE
https://www.suanfarma.com/apis-3/targeting-breast-cancer-with-precision-ribociclib-succinate-a-leading-cdk-4-6-inhibitor/
10 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/longer-term-novartis-kisqali-natalee-data-show-durable-reduction-in-distant-recurrence-in-broad-population-of-patients-with-early-breast-cancer-302327614.html
Share 